PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.66%
Some net income increase while MRVL is negative at -16.97%. John Neff would see a short-term edge over the struggling competitor.
-2.06%
Negative yoy D&A while MRVL is 0.84%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
12.28%
Lower deferred tax growth vs. MRVL's 93.75%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-21.43%
Both cut yoy SBC, with MRVL at -2.07%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
231.82%
Well above MRVL's 152.79% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-17.50%
AR is negative yoy while MRVL is 59.89%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
378.05%
Inventory growth well above MRVL's 186.83%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-41.18%
Both negative yoy AP, with MRVL at -2865.79%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
358.10%
Growth well above MRVL's 101.83%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-23.08%
Negative yoy while MRVL is 20.56%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
71.83%
Operating cash flow growth above 1.5x MRVL's 24.01%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-11.20%
Both yoy lines negative, with MRVL at -27.13%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
11.20%
Some acquisitions while MRVL is negative at -120.03%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
50.05%
Some yoy expansion while MRVL is negative at -191.48%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
13.95%
Proceeds from sales/maturities above 1.5x MRVL's 8.20%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-14.78%
Both yoy lines negative, with MRVL at -18003.70%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
323.56%
We have mild expansions while MRVL is negative at -1486.96%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-200.00%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-31.37%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-20.80%
Both yoy lines negative, with MRVL at -6875.98%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.